Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
leuprorelinacetat 15 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
Is a |
antineoplastisk middel |
false |
Inferred relationship |
Some |
|
|
leuprorelinacetat 15 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
Is a |
leuprorelinacetat |
false |
Inferred relationship |
Some |
|
|
leuprorelinacetat 15 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Leuprorelin acetate |
false |
Inferred relationship |
Some |
|
|
leuprorelinacetat 15 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hormone |
false |
Inferred relationship |
Some |
|
|
leuprorelinacetat 15 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
syntetisk hormonmiddel |
false |
Inferred relationship |
Some |
|
|
leuprorelinacetat 15 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
leuprorelinacetat 15 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Gonadotropin |
false |
Inferred relationship |
Some |
|
|
leuprorelinacetat 15 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
Is a |
Product manufactured as parenteral dose form (product) |
false |
Inferred relationship |
Some |
|
|
leuprorelinacetat 15 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
Is a |
Product containing leuprorelin in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|